Share chart Longboard Pharmaceuticals, Inc.
Extended chart
Simple chart
Main settings
Currency
usd
IPO Time
2021-03-12
ISIN
US54300N1037
Industry
Biotechnology
Report Currency
usd
Sector
Health Care
Website
Grade
Underestimation
Title | Value | Grade |
P/S | 0 | 0 |
P/BV | 3.44 | 5 |
P/E | 0 | 0 |
Efficiency
Title | Value | Grade |
ROA | -107.35 | 0 |
ROE | -132.99 | 0 |
ROIC | 0 | 0 |
Dividends
Title | Value | Grade |
Dividend yield | 0 | 0 |
DSI | 0 | 0 |
Average dividend growth | 0 | 0 |
Debt
Title | Value | Grade |
Debt/EBITDA | -0.0084 | 10 |
Debt/Ratio | 0.0094 | 10 |
Debt/Equity | 0.2388 | 10 |
Growth impulse
Title | Value | Grade |
Revenue, bln, % | 0 | 0 |
Ebitda, % | 294.13 | 10 |
EPS, % | 181.33 | 10 |
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 59.98 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
Week | 59.98 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
Month | 59.98 $ | 59.98 $ | 59.98 $ | 0 % | 0 % | 0 % |
Three month | 59.98 $ | 59.98 $ | 59.98 $ | 0 % | 0 % | 0 % |
Half a year | 59.98 $ | 59.98 $ | 59.98 $ | 0 % | 0 % | 0 % |
Year | 35.54 $ | 33.36 $ | 59.98 $ | +68.77 % | 0 % | 0 % |
3 years | 7.25 $ | 2.95 $ | 59.98 $ | +727.31 % | 0 % | 0 % |
5 years | 2.95 $ | 2.95 $ | 59.98 $ | +2 033.22 % | 0 % | 0 % |
10 years | 2.95 $ | 2.95 $ | 59.98 $ | +2 033.22 % | 0 % | 0 % |
Year to date | 59.98 $ | 59.98 $ | 59.98 $ | 0 % | 0 % | 0 % |
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
iShares Morningstar Small-Cap Value ETF | 0.02069 | 173.73 | 0.06 |
iShares Morningstar Small-Cap ETF | 0.01851 | 293.87 | 0.25 |
iShares Morningstar Small-Cap Growth ETF | 0.01676 | 529.83 | 0.06 |
0.02 | 332.48 | 0.12 |
---|
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
Mr. Kevin R. Lind | President, CEO, Secretary & Director | 1.07M | 1976 (49 years) |
Ms. Brandi L. Roberts CPA, M.B.A. | Executive VP & CFO | 662.65k | 1974 (51 year) |
Dr. Randall E. Kaye M.D. | Executive VP & Chief Medical Officer | 717.95k | 1962 (63 years) |
Mr. Chadwick J. Orevillo MPH | Executive VP & Head of Operations | N/A | |
Mr. Steven W. Spector J.D. | Executive VP, Head of Business Development & General Counsel | N/A | 1965 (60 years) |
Dr. Anne M. Danks Ph.D. | VP & Head of Nonclinical Research & Development | N/A | |
Mr. Gus Cardenas | VP & Head of Quality Assurance | N/A | |
Dr. Marco Peters Ph.D. | VP & Head of Translational Science | N/A | |
Dr. Dewey McLin Ph.D. | VP & Head of Medical Affairs | N/A | |
Ms. Megan E. Knight | VP & Head of Investor Relations |
About company
Address: United States, La Jolla. CA, 4275 Executive Square - Open in google maps, Open in yandex maps
Website: https://www.longboardpharma.com
Website: https://www.longboardpharma.com